Abeona Therapeutics Inc. - Common Stock (NQ:ABEO)

5.030 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abeona Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

PXMD, GETY: The Top 5 Short Squeeze Stocks to Watch This Week ↗

November 21, 2022

We're checking in on the top short squeeze stocks to watch this week as traders continue to have an interest in this part of the market!

Via InvestorPlace

PaxMedica, Getty Images And 3 Short Squeeze Candidates That Could Soar This Week ↗

November 21, 2022

Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move.

Via Benzinga

Abeona Therapeutics Reports Third Quarter 2022 Financial Results

November 14, 2022

From Abeona Therapeutics Inc.

Via GlobeNewswire

Cantor Bullish On Abeona Saying Recent Trial Data 'Best Case Scenario' ↗

November 08, 2022

Via Benzinga

Abeona Therapeutics Touts Positive Data From Pivotal EB-101 Study In Blistering Skin Disorder ↗

November 03, 2022

Via Benzinga

Recap: Abeona Therapeutics Q2 Earnings ↗

August 11, 2022

Abeona Therapeutics (NASDAQ:ABEO) reported its Q2 earnings results on Thursday, August 11, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Recap: Abeona Therapeutics Q1 Earnings ↗

May 13, 2022

Abeona Therapeutics (NASDAQ:ABEO) reported its Q1 earnings results on Friday, May 13, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Abeona Therapeutics: Q1 Earnings Insights ↗

May 13, 2022

Abeona Therapeutics (NASDAQ:ABEO) reported its Q1 earnings results on Friday, May 13, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Abeona Therapeutics Announces $35 Million Private Placement Financing

November 03, 2022

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics Announces Positive Topline Results with Both Co-Primary Endpoints Met in Pivotal Phase 3 VIITAL™ Study of EB-101

November 03, 2022

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics Announces Database Lock for Pivotal Phase 3 VIITAL™ Study of EB-101 in Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)

October 19, 2022

From Abeona Therapeutics Inc.

Via GlobeNewswire

Why Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday ↗

October 17, 2022

Gainers Agrify Corporation (NASDAQ: AGFY) climbed 53.8% to close at $1.45. FedNat Holding Company (NASDAQ: FNHC) gained 48% to settle at $0.52.

Via Benzinga

How Is The Market Feeling About Abeona Therapeutics? ↗

October 07, 2022

Abeona Therapeutics's (NASDAQ:ABEO) short percent of float has fallen 9.04% since its last report. The company recently reported that it has 177 thousand shares sold short, which is 3.02% of all...

Via Benzinga

Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday ↗

October 10, 2022

Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 07, 2022

Gainers Inventiva (NASDAQ:IVA) shares increased by 44.0% to $5.88 during Friday's regular session. The market value of their outstanding shares is at $247.6 million.

Via Benzinga

Why Aehr Test Systems Shares Are Trading Higher By Over 19%, Here Are 51 Stocks Moving In Friday's Mid-Day Session ↗

October 07, 2022

Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 108% to $3.3943 on abnormally-high volume. The company released its October investor presentation yesterday.

Via Benzinga

Abeona Therapeutics Announces Completion of Patient Follow-up in Pivotal Phase 3 VIITAL™ Study of EB-101 in Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)

October 04, 2022

Topline VIITAL™ study results expected within the next month

From Abeona Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 04, 2022

Via Benzinga

Tesla, Twitter And 76 Biggest Movers From Friday ↗

July 11, 2022

Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board...

Via Benzinga

This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday ↗

July 08, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.

Via Benzinga

The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study ↗

July 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 05, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

July 05, 2022

It's time to dive into all of the latest stock market news for Tuesday morning as we go over the biggest pre-market stock movers!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 30, 2022

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

June 10, 2022

Good morning, investors! With another day starting comes another breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 09, 2022

Gainers Reshape Lifesciences (NASDAQ:RSLS) shares rose 9.4% to $0.81 during Thursday's after-market session. The market value of their outstanding shares is at $2.8 million.

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation ↗

May 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 12, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 04, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 11, 2022

Gainers CVRx (NASDAQ:CVRX) shares rose 11.6% to $7.2 during Friday's after-market session. The market value of their outstanding shares is at $156.2 million.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.